Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, USA.
J Biomed Mater Res A. 2011 Nov;99(2):184-91. doi: 10.1002/jbm.a.33174. Epub 2011 Aug 16.
In a variety of biomedical applications (e.g., tissue engineering, drug delivery, etc.), the role of a bioactive material is to serve as a platform by which one can modulate the cellular response into a desired role. Of the methods by which one may achieve this control (e.g., shape, structure, binding, growth factor release), the control of the cellular redox state has been under evaluated. Ideally, the ability to tune the redox state of a cell provides an additional level of control over a variety of cellular responses including, cell differentiation, proliferation, and apoptosis. Yet, in order to achieve such control, it is important to know both the overall oxidative status of the cell and what molecular targets are being oxidized. In this work, poly (trolox ester) nanoparticles were evaluated for their ability to either inhibit or induce cellular oxidative stress in a dose-dependent fashion. This polymer delivery form possessed a unique ability to suppress protein oxidation, a feature not seen in the free drug form, emphasizing the advantage of the delivery/dosage formulation has upon regulating cellular response.
在各种生物医学应用中(例如组织工程、药物输送等),生物活性材料的作用是作为一个平台,通过它可以调节细胞反应达到预期的效果。为了实现这种控制(例如形状、结构、结合、生长因子释放),人们对细胞氧化还原状态的控制评估不足。理想情况下,调节细胞氧化还原状态的能力为细胞的各种反应(包括细胞分化、增殖和凋亡)提供了额外的控制水平。然而,为了实现这种控制,了解细胞的整体氧化状态以及哪些分子靶点正在被氧化是很重要的。在这项工作中,聚(trolox 酯)纳米粒子被评估为能够以剂量依赖的方式抑制或诱导细胞氧化应激的能力。这种聚合物递送形式具有独特的抑制蛋白质氧化的能力,这在游离药物形式中是看不到的,这强调了递送/剂量配方在调节细胞反应方面的优势。